 | • レポートコード：GIR-105X17827 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Medical Devices & Consumables |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、トランスレーショナル再生医療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。トランスレーショナル再生医療の種類別市場規模（幹細胞治療、組織エンジニアリング、遺伝子治療）、用途別市場規模（組織エンジニアリング療法、創傷治癒、軟骨修復、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・トランスレーショナル再生医療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Athersys、Avita Medical、AxoGen、MEDIPOST、NuVasive、Astellas Pharma、Organogenesis Holdings、Osiris Therapeutics、Pharmicell、Regenerys、Takeda Pharmaceutical、uniQure、Vericel ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：幹細胞治療、組織エンジニアリング、遺伝子治療 ・用途別分析2016年-2026年：組織エンジニアリング療法、創傷治癒、軟骨修復、その他 ・トランスレーショナル再生医療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・トランスレーショナル再生医療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・トランスレーショナル再生医療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・トランスレーショナル再生医療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・トランスレーショナル再生医療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Translational Regenerative Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Translational Regenerative Medicine size is estimated to be xx million in 2020 from USD 11320 million in 2019, with a change of XX% between 2019 and 2020. The global Translational Regenerative Medicine market size is expected to grow at a CAGR of 12.9% for the next five years.
Market segmentation
Translational Regenerative Medicine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Stem Cell Therapy
Tissue Engineering
Gene Therapy
Market segment by Application can be divided into
Tissue Engineering Therapy
Wound Healing
Cartilage Repair
Other
The key market players for global Translational Regenerative Medicine market are listed below:
Athersys
Avita Medical
AxoGen
MEDIPOST
NuVasive
Astellas Pharma
Organogenesis Holdings
Osiris Therapeutics
Pharmicell
Regenerys
Takeda Pharmaceutical
uniQure
Vericel
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Translational Regenerative Medicine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Translational Regenerative Medicine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Stem Cell Therapy
1.2.3 Tissue Engineering
1.2.4 Gene Therapy
1.3 Market Analysis by Application
1.3.1 Overview: Global Translational Regenerative Medicine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Tissue Engineering Therapy
1.3.3 Wound Healing
1.3.4 Cartilage Repair
1.3.5 Other
1.4 Global Translational Regenerative Medicine Market Size & Forecast
1.4.1 Global Translational Regenerative Medicine Sales in Value (2016-2026))
1.4.2 Global Translational Regenerative Medicine Sales in Volume (2016-2026)
1.4.3 Global Translational Regenerative Medicine Price by Type (2016-2026) & (USD/Unit)
1.5 Global Translational Regenerative Medicine Production Capacity Analysis
1.5.1 Global Translational Regenerative Medicine Total Production Capacity (2016-2026)
1.5.2 Global Translational Regenerative Medicine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Translational Regenerative Medicine Market Drivers
1.6.2 Translational Regenerative Medicine Market Restraints
1.6.3 Translational Regenerative Medicine Trends Analysis
2 Manufacturers Profiles
2.1 Athersys
2.1.1 Athersys Details
2.1.2 Athersys Major Business
2.1.3 Athersys Translational Regenerative Medicine Product and Services
2.1.4 Athersys Translational Regenerative Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Avita Medical
2.2.1 Avita Medical Details
2.2.2 Avita Medical Major Business
2.2.3 Avita Medical Translational Regenerative Medicine Product and Services
2.2.4 Avita Medical Translational Regenerative Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 AxoGen
2.3.1 AxoGen Details
2.3.2 AxoGen Major Business
2.3.3 AxoGen Translational Regenerative Medicine Product and Services
2.3.4 AxoGen Translational Regenerative Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 MEDIPOST
2.4.1 MEDIPOST Details
2.4.2 MEDIPOST Major Business
2.4.3 MEDIPOST Translational Regenerative Medicine Product and Services
2.4.4 MEDIPOST Translational Regenerative Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 NuVasive
2.5.1 NuVasive Details
2.5.2 NuVasive Major Business
2.5.3 NuVasive Translational Regenerative Medicine Product and Services
2.5.4 NuVasive Translational Regenerative Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Astellas Pharma
2.6.1 Astellas Pharma Details
2.6.2 Astellas Pharma Major Business
2.6.3 Astellas Pharma Translational Regenerative Medicine Product and Services
2.6.4 Astellas Pharma Translational Regenerative Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Organogenesis Holdings
2.7.1 Organogenesis Holdings Details
2.7.2 Organogenesis Holdings Major Business
2.7.3 Organogenesis Holdings Translational Regenerative Medicine Product and Services
2.7.4 Organogenesis Holdings Translational Regenerative Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Osiris Therapeutics
2.8.1 Osiris Therapeutics Details
2.8.2 Osiris Therapeutics Major Business
2.8.3 Osiris Therapeutics Translational Regenerative Medicine Product and Services
2.8.4 Osiris Therapeutics Translational Regenerative Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Pharmicell
2.9.1 Pharmicell Details
2.9.2 Pharmicell Major Business
2.9.3 Pharmicell Translational Regenerative Medicine Product and Services
2.9.4 Pharmicell Translational Regenerative Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Regenerys
2.10.1 Regenerys Details
2.10.2 Regenerys Major Business
2.10.3 Regenerys Translational Regenerative Medicine Product and Services
2.10.4 Regenerys Translational Regenerative Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Takeda Pharmaceutical
2.11.1 Takeda Pharmaceutical Details
2.11.2 Takeda Pharmaceutical Major Business
2.11.3 Takeda Pharmaceutical Translational Regenerative Medicine Product and Services
2.11.4 Takeda Pharmaceutical Translational Regenerative Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 uniQure
2.12.1 uniQure Details
2.12.2 uniQure Major Business
2.12.3 uniQure Translational Regenerative Medicine Product and Services
2.12.4 uniQure Translational Regenerative Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Vericel
2.13.1 Vericel Details
2.13.2 Vericel Major Business
2.13.3 Vericel Translational Regenerative Medicine Product and Services
2.13.4 Vericel Translational Regenerative Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Translational Regenerative Medicine Sales by Manufacturer
3.1 Global Translational Regenerative Medicine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Translational Regenerative Medicine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Translational Regenerative Medicine
3.4 Market Concentration Rate
3.4.1 Top 3 Translational Regenerative Medicine Manufacturer Market Share
3.4.2 Top 6 Translational Regenerative Medicine Manufacturer Market Share
3.5 Global Translational Regenerative Medicine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Translational Regenerative Medicine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Translational Regenerative Medicine Market Size by Region
4.1.1 Global Translational Regenerative Medicine Sales in Volume by Region (2016-2026)
4.1.2 Global Translational Regenerative Medicine Revenue by Region (2016-2026)
4.2 North America Translational Regenerative Medicine Revenue (2016-2026)
4.3 Europe Translational Regenerative Medicine Revenue (2016-2026)
4.4 Asia-Pacific Translational Regenerative Medicine Revenue (2016-2026)
4.5 South America Translational Regenerative Medicine Revenue (2016-2026)
4.6 Middle East and Africa Translational Regenerative Medicine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Translational Regenerative Medicine Sales in Volume by Type (2016-2026)
5.2 Global Translational Regenerative Medicine Revenue by Type (2016-2026)
5.3 Global Translational Regenerative Medicine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Translational Regenerative Medicine Sales in Volume by Application (2016-2026)
6.2 Global Translational Regenerative Medicine Revenue by Application (2016-2026)
6.3 Global Translational Regenerative Medicine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Translational Regenerative Medicine Sales by Type (2016-2026)
7.2 North America Translational Regenerative Medicine Sales by Application (2016-2026)
7.3 North America Translational Regenerative Medicine Market Size by Country
7.3.1 North America Translational Regenerative Medicine Sales in Volume by Country (2016-2026)
7.3.2 North America Translational Regenerative Medicine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Translational Regenerative Medicine Sales by Type (2016-2026)
8.2 Europe Translational Regenerative Medicine Sales by Application (2016-2026)
8.3 Europe Translational Regenerative Medicine Market Size by Country
8.3.1 Europe Translational Regenerative Medicine Sales in Volume by Country (2016-2026)
8.3.2 Europe Translational Regenerative Medicine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Translational Regenerative Medicine Sales by Type (2016-2026)
9.2 Asia-Pacific Translational Regenerative Medicine Sales by Application (2016-2026)
9.3 Asia-Pacific Translational Regenerative Medicine Market Size by Region
9.3.1 Asia-Pacific Translational Regenerative Medicine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Translational Regenerative Medicine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Translational Regenerative Medicine Sales by Type (2016-2026)
10.2 South America Translational Regenerative Medicine Sales by Application (2016-2026)
10.3 South America Translational Regenerative Medicine Market Size by Country
10.3.1 South America Translational Regenerative Medicine Sales in Volume by Country (2016-2026)
10.3.2 South America Translational Regenerative Medicine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Translational Regenerative Medicine Sales by Type (2016-2026)
11.2 Middle East & Africa Translational Regenerative Medicine Sales by Application (2016-2026)
11.3 Middle East & Africa Translational Regenerative Medicine Market Size by Country
11.3.1 Middle East & Africa Translational Regenerative Medicine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Translational Regenerative Medicine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Translational Regenerative Medicine Typical Distributors
12.3 Translational Regenerative Medicine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Translational Regenerative Medicine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Translational Regenerative Medicine Revenue by Application, (USD Million), 2021-2026
Table 3. Athersys Basic Information, Manufacturing Base and Competitors
Table 4. Athersys Major Business
Table 5. Athersys Translational Regenerative Medicine Product and Services
Table 6. Athersys Translational Regenerative Medicine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Avita Medical Basic Information, Manufacturing Base and Competitors
Table 8. Avita Medical Major Business
Table 9. Avita Medical Translational Regenerative Medicine Product and Services
Table 10. Avita Medical Translational Regenerative Medicine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. AxoGen Basic Information, Manufacturing Base and Competitors
Table 12. AxoGen Major Business
Table 13. AxoGen Translational Regenerative Medicine Product and Services
Table 14. AxoGen Translational Regenerative Medicine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. MEDIPOST Basic Information, Manufacturing Base and Competitors
Table 16. MEDIPOST Major Business
Table 17. MEDIPOST Translational Regenerative Medicine Product and Services
Table 18. MEDIPOST Translational Regenerative Medicine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. NuVasive Basic Information, Manufacturing Base and Competitors
Table 20. NuVasive Major Business
Table 21. NuVasive Translational Regenerative Medicine Product and Services
Table 22. NuVasive Translational Regenerative Medicine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Astellas Pharma Major Business
Table 25. Astellas Pharma Translational Regenerative Medicine Product and Services
Table 26. Astellas Pharma Translational Regenerative Medicine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Organogenesis Holdings Basic Information, Manufacturing Base and Competitors
Table 28. Organogenesis Holdings Major Business
Table 29. Organogenesis Holdings Translational Regenerative Medicine Product and Services
Table 30. Organogenesis Holdings Translational Regenerative Medicine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Osiris Therapeutics Basic Information, Manufacturing Base and Competitors
Table 32. Osiris Therapeutics Major Business
Table 33. Osiris Therapeutics Translational Regenerative Medicine Product and Services
Table 34. Osiris Therapeutics Translational Regenerative Medicine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Pharmicell Basic Information, Manufacturing Base and Competitors
Table 36. Pharmicell Major Business
Table 37. Pharmicell Translational Regenerative Medicine Product and Services
Table 38. Pharmicell Translational Regenerative Medicine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Regenerys Basic Information, Manufacturing Base and Competitors
Table 40. Regenerys Major Business
Table 41. Regenerys Translational Regenerative Medicine Product and Services
Table 42. Regenerys Translational Regenerative Medicine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Takeda Pharmaceutical Major Business
Table 45. Takeda Pharmaceutical Translational Regenerative Medicine Product and Services
Table 46. Takeda Pharmaceutical Translational Regenerative Medicine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. uniQure Basic Information, Manufacturing Base and Competitors
Table 48. uniQure Major Business
Table 49. uniQure Translational Regenerative Medicine Product and Services
Table 50. uniQure Translational Regenerative Medicine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Vericel Basic Information, Manufacturing Base and Competitors
Table 52. Vericel Major Business
Table 53. Vericel Translational Regenerative Medicine Product and Services
Table 54. Vericel Translational Regenerative Medicine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Translational Regenerative Medicine Sales by Manufacturer (2019-2021e) & (K Units)
Table 56. Global Translational Regenerative Medicine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Translational Regenerative Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Translational Regenerative Medicine Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Translational Regenerative Medicine Production Site of Key Manufacturer
Table 60. Global Translational Regenerative Medicine Sales by Region (2016-2021e) & (K Units)
Table 61. Global Translational Regenerative Medicine Sales by Region (2021-2026) & (K Units)
Table 62. Global Translational Regenerative Medicine Revenue by Region (2016-2021e) & (USD Million)
Table 63. Global Translational Regenerative Medicine Revenue by Region (2021-2026) & (USD Million)
Table 64. Global Translational Regenerative Medicine Sales by Type (2016-2021e) & (K Units)
Table 65. Global Translational Regenerative Medicine Sales by Type (2021-2026) & (K Units)
Table 66. Global Translational Regenerative Medicine Revenue by Type (2016-2021e) & (USD Million)
Table 67. Global Translational Regenerative Medicine Revenue by Type (2021-2026) & (USD Million)
Table 68. Global Translational Regenerative Medicine Price by Type (2016-2021e) & (USD/Unit)
Table 69. Global Translational Regenerative Medicine Price by Type (2021-2026) & (USD/Unit)
Table 70. Global Translational Regenerative Medicine Sales by Application (2016-2021e) & (K Units)
Table 71. Global Translational Regenerative Medicine Sales by Application (2021-2026) & (K Units)
Table 72. Global Translational Regenerative Medicine Revenue by Application (2016-2021e) & (USD Million)
Table 73. Global Translational Regenerative Medicine Revenue by Application (2021-2026) & (USD Million)
Table 74. Global Translational Regenerative Medicine Price by Application (2016-2021e) & (USD/Unit)
Table 75. Global Translational Regenerative Medicine Price by Application (2021-2026) & (USD/Unit)
Table 76. North America Translational Regenerative Medicine Sales by Country (2016-2021e) & (K Units)
Table 77. North America Translational Regenerative Medicine Sales by Country (2021-2026) & (K Units)
Table 78. North America Translational Regenerative Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 79. North America Translational Regenerative Medicine Revenue by Country (2021-2026) & (USD Million)
Table 80. North America Translational Regenerative Medicine Sales by Type (2016-2021e) & (K Units)
Table 81. North America Translational Regenerative Medicine Sales by Type (2021-2026) & (K Units)
Table 82. North America Translational Regenerative Medicine Sales by Application (2016-2021e) & (K Units)
Table 83. North America Translational Regenerative Medicine Sales by Application (2021-2026) & (K Units)
Table 84. Europe Translational Regenerative Medicine Sales by Country (2016-2021e) & (K Units)
Table 85. Europe Translational Regenerative Medicine Sales by Country (2021-2026) & (K Units)
Table 86. Europe Translational Regenerative Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 87. Europe Translational Regenerative Medicine Revenue by Country (2021-2026) & (USD Million)
Table 88. Europe Translational Regenerative Medicine Sales by Type (2016-2021e) & (K Units)
Table 89. Europe Translational Regenerative Medicine Sales by Type (2021-2026) & (K Units)
Table 90. Europe Translational Regenerative Medicine Sales by Application (2016-2021e) & (K Units)
Table 91. Europe Translational Regenerative Medicine Sales by Application (2021-2026) & (K Units)
Table 92. Asia-Pacific Translational Regenerative Medicine Sales by Region (2016-2021e) & (K Units)
Table 93. Asia-Pacific Translational Regenerative Medicine Sales by Region (2021-2026) & (K Units)
Table 94. Asia-Pacific Translational Regenerative Medicine Revenue by Region (2016-2021e) & (USD Million)
Table 95. Asia-Pacific Translational Regenerative Medicine Revenue by Region (2021-2026) & (USD Million)
Table 96. Asia-Pacific Translational Regenerative Medicine Sales by Type (2016-2021e) & (K Units)
Table 97. Asia-Pacific Translational Regenerative Medicine Sales by Type (2021-2026) & (K Units)
Table 98. Asia-Pacific Translational Regenerative Medicine Sales by Application (2016-2021e) & (K Units)
Table 99. Asia-Pacific Translational Regenerative Medicine Sales by Application (2021-2026) & (K Units)
Table 100. South America Translational Regenerative Medicine Sales by Country (2016-2021e) & (K Units)
Table 101. South America Translational Regenerative Medicine Sales by Country (2021-2026) & (K Units)
Table 102. South America Translational Regenerative Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 103. South America Translational Regenerative Medicine Revenue by Country (2021-2026) & (USD Million)
Table 104. South America Translational Regenerative Medicine Sales by Type (2016-2021e) & (K Units)
Table 105. South America Translational Regenerative Medicine Sales by Type (2021-2026) & (K Units)
Table 106. South America Translational Regenerative Medicine Sales by Application (2016-2021e) & (K Units)
Table 107. South America Translational Regenerative Medicine Sales by Application (2021-2026) & (K Units)
Table 108. Middle East & Africa Translational Regenerative Medicine Sales by Country (2016-2021e) & (K Units)
Table 109. Middle East & Africa Translational Regenerative Medicine Sales by Country (2021-2026) & (K Units)
Table 110. Middle East & Africa Translational Regenerative Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 111. Middle East & Africa Translational Regenerative Medicine Revenue by Country (2021-2026) & (USD Million)
Table 112. Middle East & Africa Translational Regenerative Medicine Sales by Type (2016-2021e) & (K Units)
Table 113. Middle East & Africa Translational Regenerative Medicine Sales by Type (2021-2026) & (K Units)
Table 114. Middle East & Africa Translational Regenerative Medicine Sales by Application (2016-2021e) & (K Units)
Table 115. Middle East & Africa Translational Regenerative Medicine Sales by Application (2021-2026) & (K Units)
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Translational Regenerative Medicine Typical Distributors
Table 119. Translational Regenerative Medicine Typical Customers
List of Figures
Figure 1. Translational Regenerative Medicine Picture
Figure 2. Global Translational Regenerative Medicine Sales Market Share by Type in 2020
Figure 3. Stem Cell Therapy
Figure 4. Tissue Engineering
Figure 5. Gene Therapy
Figure 6. Global Translational Regenerative Medicine Sales Market Share by Application in 2020
Figure 7. Tissue Engineering Therapy
Figure 8. Wound Healing
Figure 9. Cartilage Repair
Figure 10. Other
Figure 11. Global Translational Regenerative Medicine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Translational Regenerative Medicine Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Translational Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Translational Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Translational Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Translational Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Translational Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Translational Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Translational Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Translational Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Translational Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Translational Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Translational Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Translational Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Translational Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Translational Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Translational Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Translational Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Translational Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Translational Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Translational Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Translational Regenerative Medicine Sales (2016-2026) & (K Units)
Figure 33. Global Translational Regenerative Medicine Production Capacity (2016-2026) & (K Units)
Figure 34. Global Translational Regenerative Medicine Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Translational Regenerative Medicine Market Drivers
Figure 36. Translational Regenerative Medicine Market Restraints
Figure 37. Translational Regenerative Medicine Market Trends
Figure 38. Global Translational Regenerative Medicine Sales Market Share by Manufacturer in 2020
Figure 39. Global Translational Regenerative Medicine Revenue Market Share by Manufacturer in 2020
Figure 40. Translational Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Translational Regenerative Medicine Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Translational Regenerative Medicine Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Translational Regenerative Medicine Sales Market Share by Region (2016-2026)
Figure 44. Global Translational Regenerative Medicine Revenue Market Share by Region (2016-2026)
Figure 45. North America Translational Regenerative Medicine Revenue (2016-2026) & (USD Million)
Figure 46. Europe Translational Regenerative Medicine Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Translational Regenerative Medicine Revenue (2016-2026) & (USD Million)
Figure 48. South America Translational Regenerative Medicine Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Translational Regenerative Medicine Revenue (2016-2026) & (USD Million)
Figure 50. Global Translational Regenerative Medicine Sales Market Share by Type (2016-2026)
Figure 51. Global Translational Regenerative Medicine Revenue Market Share by Type (2016-2026)
Figure 52. Global Translational Regenerative Medicine Price by Type (2016-2026) & (USD/Unit)
Figure 53. Global Translational Regenerative Medicine Sales Market Share by Application (2016-2026)
Figure 54. Global Translational Regenerative Medicine Revenue Market Share by Application (2016-2026)
Figure 55. Global Translational Regenerative Medicine Price by Application (2016-2026) & (USD/Unit)
Figure 56. North America Translational Regenerative Medicine Sales Market Share by Country (2016-2026)
Figure 57. North America Translational Regenerative Medicine Revenue Market Share by Country (2016-2026)
Figure 58. North America Translational Regenerative Medicine Sales Market Share by Type (2016-2026)
Figure 59. North America Translational Regenerative Medicine Sales Market Share by Application (2016-2026)
Figure 60. Europe Translational Regenerative Medicine Sales Market Share by Country (2016-2026)
Figure 61. Europe Translational Regenerative Medicine Revenue Market Share by Country (2016-2026)
Figure 62. Europe Translational Regenerative Medicine Sales Market Share by Type (2016-2026)
Figure 63. Europe Translational Regenerative Medicine Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Translational Regenerative Medicine Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Translational Regenerative Medicine Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Translational Regenerative Medicine Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Translational Regenerative Medicine Sales Market Share by Application (2016-2026)
Figure 68. South America Translational Regenerative Medicine Sales Market Share by Country (2016-2026)
Figure 69. South America Translational Regenerative Medicine Revenue Market Share by Country (2016-2026)
Figure 70. South America Translational Regenerative Medicine Sales Market Share by Type (2016-2026)
Figure 71. South America Translational Regenerative Medicine Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Translational Regenerative Medicine Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Translational Regenerative Medicine Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Translational Regenerative Medicine Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Translational Regenerative Medicine Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
変形性関節症に対する幹細胞療法の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe. Scope of the Report: This r…- 多発性硬化症に対する幹細胞療法の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…
- 糖尿病と関連疾患に対する幹細胞療法の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Diabetes is the metabolic disorder that is associated with the glucose level in the blood. It is mainly divided into two types, insulin-dependent diabetes mellitus or juvenile onset (type 1) and non-insulin-dependent diabetes mellitus, or adult-onset diabetes (type 2). Scope of the Report: This repo…
- ムコ多糖症の遺伝子治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Mucopolysaccharidosis consists of a group of more than 40 genetic disorders that forms a part of lysosomal storage disease. They are caused by an inherited deficiency of an enzyme involved in the degradation of acid glycosaminoglycans (GAGs), which was previously known as mucopolysaccharidosis. All …
- 卵巣がんの遺伝子治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…